Cargando…
Evaluation of the combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents: monoamine oxidase-B inhibition, neuroprotection and oxidative stress modulation
Neuroprotective drugs and selective monoamine oxidase inhibitors can slow down the progression and improve symptoms of Parkinson’s disease (PD). Since there is an implication of oxidative stress in the pathophysiological mechanisms of the disease, the compounds possessing an ability to reduce the ox...
Autores principales: | Anastassova, Neda, Aluani, Denitsa, Kostadinov, Anton, Rangelov, Miroslav, Todorova, Nadezhda, Hristova-Avakumova, Nadya, Argirova, Maria, Lumov, Nikolay, Kondeva-Burdina, Magdalena, Tzankova, Virginia, Yancheva, Denitsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354139/ https://www.ncbi.nlm.nih.gov/pubmed/33818516 http://dx.doi.org/10.4103/1673-5374.309843 |
Ejemplares similares
-
Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson’s Disease
por: Anastassova, Neda, et al.
Publicado: (2022) -
New Indole-3-Propionic Acid and 5-Methoxy-Indole Carboxylic Acid Derived Hydrazone Hybrids as Multifunctional Neuroprotectors
por: Anastassova, Neda, et al.
Publicado: (2023) -
New 1H-benzimidazole-2-yl hydrazones with combined antiparasitic and antioxidant activity
por: Argirova, Maria A., et al.
Publicado: (2021) -
Modulation Effect on Tubulin Polymerization, Cytotoxicity and Antioxidant Activity of 1H-Benzimidazole-2-Yl Hydrazones
por: Argirova, Maria, et al.
Publicado: (2022) -
Preliminary in vitro evaluation of neuroprotective and monoamine oxidase type B inhibitory effects of newly synthesized 8-aminocaffeines
por: Kondeva-Burdina, Magdalena, et al.
Publicado: (2019)